INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 19 filers reported holding INFLARX NV in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -99.9% | 1,000 | -98.8% | 0.00% | -100.0% |
| Q1 2019 | $3,261,000 | +156.4% | 86,317 | +146.6% | 0.00% | +100.0% |
| Q4 2018 | $1,272,000 | -54.9% | 35,000 | -57.4% | 0.00% | 0.0% |
| Q3 2018 | $2,820,000 | +23.9% | 82,192 | +16.4% | 0.00% | 0.0% |
| Q2 2018 | $2,276,000 | +125.6% | 70,600 | +101.7% | 0.00% | – |
| Q1 2018 | $1,009,000 | +37.7% | 35,000 | 0.0% | 0.00% | – |
| Q4 2017 | $733,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Investment Advisers, LLC | 210,000 | $963,000 | 0.56% |
| Birchview Capital, LP | 70,000 | $321,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 34,151 | $157,000 | 0.09% |
| Ikarian Capital, LLC | 152,600 | $700,000 | 0.06% |
| Leap Investments LP | 18,500 | $85,000 | 0.06% |
| Orbimed Advisors | 678,525 | $3,114,000 | 0.04% |
| PERSONAL CFO SOLUTIONS, LLC | 15,888 | $73,000 | 0.02% |
| Baker Brothers Advisors | 1,058,555 | $4,859,000 | 0.02% |
| Verition Fund Management LLC | 95,000 | $436,000 | 0.01% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 28,000 | $129,000 | 0.01% |